Cost Implications of Successful Hand Hygiene Promotion

2004 ◽  
Vol 25 (3) ◽  
pp. 264-266 ◽  
Author(s):  
Didier Pittet ◽  
Hugo Sax ◽  
Stéphane Hugonnet ◽  
Stephan Harbarth
Keyword(s):  
Cost Saving ◽  
Hand Hygiene ◽  
Nosocomial Infections ◽  
Total Cost ◽  
Hygiene Promotion ◽  
Cost Implications

AbstractWe evaluated the costs associated with a sustained and successful campaign for hand hygiene promotion that emphasized alcohol-based handrubs. The total cost of the hand hygiene promotion corresponded to less than 1% of the costs associated with nosocomial infections. Successful hand hygiene promotion is probably cost-saving.

A nudge-based smart system for hand hygiene promotion in private organizations

2020 ◽  
Author(s):  
Sopicha Stirapongsasuti ◽  
Kundjanasith Thonglek ◽  
Shinya Misaki ◽  
Bunyapon Usawalertkamol ◽  
Yugo Nakamura ◽  
...  
Keyword(s):  
Hand Hygiene ◽  
Smart System ◽  
Private Organizations ◽  
Hygiene Promotion

Reduction of Health Care Associated Infection Risk in Neonates by Successful Hand Hygiene Promotion

PEDIATRICS ◽  
2007 ◽  
Vol 120 (2) ◽  
pp. e382-e390 ◽  
Author(s):  
C. L. Pessoa-Silva ◽  
S. Hugonnet ◽  
R. Pfister ◽  
S. Touveneau ◽  
S. Dharan ◽  
...  
Keyword(s):  
Health Care ◽  
Hand Hygiene ◽  
Infection Risk ◽  
Hygiene Promotion ◽  
Health Care Associated Infection

scholarly journals Hand hygiene promotion in a university and tertiary hospital in the north of Portugal

2012 ◽  
Vol 16 ◽  
pp. e387
Author(s):  
A. Fernandes ◽  
E. Aires ◽  
P. Rodrigues ◽  
C. Vasconcelos
Keyword(s):  
Hand Hygiene ◽  
Tertiary Hospital ◽  
The North ◽  
Hygiene Promotion

Hand hygiene promotion delivered by change agents—Two attitudes, similar outcome

2020 ◽  
Vol 41 (3) ◽  
pp. 273-279 ◽  
Author(s):  
Yew Fong Lee ◽  
Mary-Louise McLaws ◽  
Loke Meng Ong ◽  
Suraya Amir Husin ◽  
Hock Hin Chua ◽  
...  
Keyword(s):  
Hand Hygiene ◽  
Hand Hygiene Compliance ◽  
Tertiary Care ◽  
Change Agents ◽  
Controlled Study ◽  
Care Hospital ◽  
Hand Hygiene Improvement ◽  
Significant Difference ◽  
Hygiene Promotion ◽  
Hygiene Compliance

AbstractObjective:To assess the effect of peer-identified change agents (PICAs) compared to management-selected change agents (MSCAs) on hand hygiene behavior in acute care.Design:Randomized-controlled study.Setting:Two internal medicine wards of a public, university-affiliated, tertiary-care hospital in Malaysia.Methods:We randomly allocated 2 wards to hand hygiene promotion delivered either by PICAs (study arm 1) or by MSCAs (study arm 2). The primary outcome was hand hygiene compliance using direct observation by validated auditors. Secondary outcomes were hand hygiene knowledge and observations from ward tours.Results:Mean hand hygiene compliance in study arm 1 and study arm 2 improved from 48% (95% confidence interval [CI], 44%–53%) and 50% (95% CI, 44%–55%) in the preintervention period to 66% (63%–69%) and 65% (60%–69%) in the intervention period, respectively. We detected no statistically significant difference in hand hygiene improvement between the 2 study arms. Knowledge scores on hand hygiene in study arm 1 and study arm 2 improved from 60% and 63% to 98% and 93%, respectively. Staff in study arm 1 improved hand hygiene because they did not want to disappoint the efforts taken by the PICAs. Staff in study arm 2 felt pressured by the MSCAs to comply with hand hygiene to obtain good overall performance appraisals.Conclusion:Although the attitude of PICAs and MSCAs in terms of leadership, mode of action and perception of their task by staff were very different, or even opposed, both PICAs and MSCAs effectively changed behavior of staff toward improved hand hygiene to comparable levels.

Research on Supply Chain Profit Coordination Mechanism Based on JIT Lot-Splitting

2013 ◽  
Vol 694-697 ◽  
pp. 3466-3471
Author(s):  
Qin Lv
Keyword(s):  
Supply Chain ◽  
Cost Saving ◽  
Bargaining Power ◽  
Simulation Analysis ◽  
Coordination Mechanism ◽  
Two Stage ◽  
Total Cost ◽  
Lot Splitting ◽  
The Impact ◽  
Stackelberg Leader

A supply chain profit coordination mechanism based on JIT lot-splitting, which involves a two stage supply chain consisted of a supplier and a buyer, is discussed. Based on the bargaining power of supplier, the profit coordination with and without incentives are respectively explored. For the total cost minimizations of buyer and supplier separately, two stage stackelberg leader-follower game models, in which buyer is the leader and supplier is the follower, are established. Supplier applies JIT delivery to reduce buyer’s cost and the total cost of the supply chain via dividing buyer’s order per batch into some batches to deliver. Finally, a numerical example and a simulation analysis are given and the impact of the variation of relative parameters on the total cost saving of buyer, supplier and system is discussed. In addition, the efficiency of game decision on the basis of JIT lot-splitting is proved.

Cost implications of growth in new cancer drugs in a comprehensive cancer center.

2019 ◽  
Vol 37 (27_suppl) ◽  
pp. 112-112
Author(s):  
Sukanya Murali Venkatesan ◽  
Anamika Chaudhuri ◽  
Belen Fraile
Keyword(s):  
Care Delivery ◽  
Fiscal Year ◽  
Comprehensive Cancer Center ◽  
Cancer Center ◽  
Cancer Therapies ◽  
Hospital Data ◽  
Total Cost ◽  
Number Of Patients ◽  
Number Of Visits ◽  
Cost Implications

112 Background: Rising costs of cancer therapies calls for strategizing towards sustainable care delivery models from a hospital planning, payer as well as policy-making perspective. This topic becomes increasingly significant as there is exponential growth of novel, high-cost immunotherapy drugs making it imperative for players to adopt and practice value-based oncology. Objective: This study aims to evaluate increasing trends in use of new and transformative cancer therapies, and associated drug costs in a comprehensive cancer center in Massachusetts. Methods: Study period was fiscal year (FY) 2015-2018. Utilization was defined by the number of patients receiving infusion and number of visits made by them to the center during the FY. Cost was defined as expense to hospital. Data source was hospital billing database. ASP (Average Sales Price) of drug was obtained from CMS website and was used as an indicator for cost per unit of the drug. Results: Top 10 drugs were identified based on total cost incurred in the study period and contributed to almost a third of center’s total cost. Over the three years, number of visits for these drugs grew up to 700% and treated patients grew up to 350%. Use of chemotherapy in isolation decreased from 35% of treated patients in FY15 to 26% in FY18, whereas its use in combination with immunotherapy increased from 22% in FY15 to 28% in FY18. Average drug cost to hospital per patient for the study period ranged as high as $120,000 (excluding non-drug treatment costs). Conclusions: While clinical value of the new cancer therapies is unquestionably significant, there is a dire need for policy-makers, providers and payers alike to pay continued attention towards its high cost implications as observed in this study and, continue striving towards establishing more sustainable pricing policies through alternative payment models.

Sign in / Sign up

Export Citation Format

Share Document